Telo Genomics Corp (TELO : TSX-V)
Common Stock
$0.04
CAD
+0.00 (%)
Last updated: 2026-07-20
TELO
Telo Genomics Corp
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
-10.00%
YTD
-10.00%
Key Statistics
Market Cap
$4.52M
52W High
$0.10
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.05
200 Day MA
$0.05
Beta
0.18
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 22,000 |
| 7/9/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 10,000 |
| 7/7/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 13,000 |
| 7/6/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 35,000 |
| 7/3/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 0 |
| 7/2/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 9,203 |
| 6/30/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 61,000 |
| 6/29/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 4,900 |
| 6/26/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 139,000 |
| 6/25/2026 | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 0 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELO's historical volatility
30-Day Vol
115.6%
Annualized
90-Day Vol
116.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.04 | C$0.03 – C$0.06 |
| 60 trading days | C$0.04 | C$0.02 – C$0.07 |
| 90 trading days | C$0.04 | C$0.02 – C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Telo Genomics Corp
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smoldering Multiple Myeloma) for SMM patients with a high risk of transition to multiple myeloma (MM). The company also develops TeloView NDMM, which predicts newly diagnosed MM patients who may relapse on first-line therapy; TeloMRD-D, which identifies and enumerates MRD cells in post-transplant patients; and TeloViewNG-MRD (Minimal Residual Disease) Profiling for genomic instability profiling of MRD-detected cells in post-transplant patients. It has a collaboration agreement with the Mayo Clinic. Telo Genomics Corp. is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-1.87M
- Profit Margin
- 0.00%
- ROE (TTM)
- -4675.28%
- EPS (Diluted)
- -0.03
- Book Value
- -0.01
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About TELO
Articles Featuring TELO.V
Latest articles and analysis covering TELO.V
Why Telo Genomics Corp stock is plummeting today
Telo Genomics Corp's stock plummeted 11.11% today, closing at CA$0.04. This decline is particularly concerning given the company's recent lack of positive news and the potential implications for its future performance.
Why Telo Genomics Corp stock is skyrocketing today
Telo Genomics Corp's stock soared by 12.50% today, closing at CA$0.04, driven by renewed investor interest and potential strategic developments within the company.
Why Telo Genomics Corp stock is plummeting today
Telo Genomics Corp's stock plummeted by over 11% today, closing at CA$0.04. With no significant news to explain the decline, investors are left questioning the stability of the company amidst its recent initiatives.
Why Telo Genomics Corp stock is plummeting today
Telo Genomics Corp's stock price has taken a significant hit, dropping 11.11% in today's trading session. With no recent news to explain the decline, investors are left questioning the company's future.
Why Telo Genomics Corp stock is plummeting today
Telo Genomics Corp (TELO.V) saw its stock plummet by 11.11% today, closing at CA$0.04. This decline highlights potential investor apprehensions regarding the company's future amidst its recent operational expansions and leadership changes.
Why Telo Genomics Corp stock is skyrocketing today
Telo Genomics Corp stock soared 12.50% in the last session, closing at CA$0.04. The company's recent leadership changes and strategic initiatives may be driving this positive momentum.
Why Telo Genomics Corp stock is plummeting today
Telo Genomics Corp's stock has dropped 12.50% today, closing at CA$0.04. This decline raises questions about the company's market position and future prospects in the competitive biotech landscape.
Why Telo Genomics Corp stock is plummeting today
Telo Genomics Corp's stock has dropped significantly today, raising concerns among investors about the company's future prospects despite recent operational expansions.
